Sialic Acid-Targeting Lectin-Conjugated Oxygen Nanosomes Alleviate Hypoxia and Promote Macrophage Activation in Pancreatic Cancer Cells
International Journal of Nanomedicine · 2026
DOI: 10.2147/ijn.s630472 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Yerin Jang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrative Engineering, Chung-Ang University, Seoul, 06974, Republic of Korea. Hauptthemen laut MEDLINE: Macrophage Activation, N-Acetylneuraminic Acid, Pancreatic Neoplasms, Oxygen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Introduction
Pancreatic ductal adenocarcinoma (PDAC) is characterized by severe hypoxia and an immunosuppressive tumor microenvironment, which contribute to poor therapeutic responses. This study developed sialic acid-targeting Lectin-conjugated oxygen nanosomes (Lectin-ONs) to combine targeted oxygen delivery with hypoxia alleviation and macrophage activation.
Methods
SNA- and MALII-conjugated oxygen nanosomes (SNA-ONs and MALII-ONs) were prepared and characterized for physicochemical properties, oxygen-loading and release behavior, stability, cytocompatibility, and cellular binding. Their effects on hypoxia and macrophage activation were evaluated in pancreatic cancer cell models and macrophage-pancreatic cancer cell co-culture using hypoxia-sensitive fluorescence and TNF-α secretion, respectively.
Results
Lectin-ONs exhibited stable physicochemical properties, effective oxygen delivery, and cellular binding to pancreatic cancer cells, while reducing hypoxia-associated fluorescence under oxygen-limited conditions. Treatment with Lectin-ONs also increased TNF-α secretion in macrophage-pancreatic cancer cell co-culture, consistent with macrophage activation.
Conclusion
Lectin-ONs integrate sialic acid-targeted delivery with oxygen-mediated hypoxia alleviation and were associated with increased macrophage TNF-α secretion in vitro. These findings support Lectin-ONs as a potential platform for modulating the hypoxic and immunosuppressive microenvironment of pancreatic cancer, although further mechanistic and in vivo validation is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Integrative Engineering, Chung-Ang University, Seoul, 06974, Republic of Korea.
- School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
- Feynman Institute of Technology, Nanomedicine Corporation, Seoul, 06974, Republic of Korea.
- Department of Chemical Engineering, Kumoh National Institute of Technology, Gyeongsangbuk-do, 39177, Republic of Korea.
- Molecular Science and Software Engineering (MSSE) Program, College of Chemistry, University of California, Berkeley, CA, 94720, USA.
ORCID-Profile: Jiwon Kim, Jaewoo Son, Jaehee Jang, Jonghoon Choi
Zitieren
APA
Jang, Y., Yang, J., Kim, J., Son, J., Jang, J., Choi, Y., Lee, H. Y., & Choi, J. (2026). Sialic Acid-Targeting Lectin-Conjugated Oxygen Nanosomes Alleviate Hypoxia and Promote Macrophage Activation in Pancreatic Cancer Cells. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s630472
Vancouver
Jang Y, Yang J, Kim J, Son J, Jang J, Choi Y, et al. Sialic Acid-Targeting Lectin-Conjugated Oxygen Nanosomes Alleviate Hypoxia and Promote Macrophage Activation in Pancreatic Cancer Cells. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s630472
BibTeX
@article{Jang2026,
author = {Jang, Yerin and Yang, Jihyuk and Kim, Jiwon and Son, Jaewoo and Jang, Jaehee and Choi, Yonghyun and Lee, Hee-Young and Choi, Jonghoon},
title = {Sialic Acid-Targeting Lectin-Conjugated Oxygen Nanosomes Alleviate Hypoxia and Promote Macrophage Activation in Pancreatic Cancer Cells},
journal = {International Journal of Nanomedicine},
year = {2026},
doi = {10.2147/ijn.s630472}
}
EUVIMED